BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 28705230)

  • 21. High Frequency of Hepatitis B Core and Surface Antibodies in Hepatitis C Virus-Infected Patients on the Screening Examination.
    Suto C; Murakami H; Kobayashi Y; Nagamine T; Saitoh T; Kasamatsu T; Ogawara H; Murakami M
    Rinsho Byori; 2015 Mar; 63(3):305-11. PubMed ID: 26524852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B virus (HBV) infection amongst children in Senegal: current prevalence and seroprotection level.
    Lô G; Sow-Sall A; Diop-Ndiaye H; Babacar N; Diouf NN; Daffé SM; Ndao B; Thiam M; Mbow M; Soumboundou MB; Lemoine M; Sylla-Niang M; Ndiaye O; Boye CS; Mboup S; Touré-Kane NC
    Pan Afr Med J; 2019; 32():140. PubMed ID: 31303913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth.
    Jafarzadeh A; Montazerifar SJ
    J Ayub Med Coll Abbottabad; 2006; 18(4):4-9. PubMed ID: 17591001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune responses to hepatitis B immunization 10-18 years after primary vaccination: a population-based cohort study.
    Katoonizadeh A; Sharafkhah M; Ostovaneh MR; Norouzi A; Khoshbakht N; Mohamadkhani A; Eslami L; Gharravi A; Shayanrad A; Khoshnia M; Esmaili S; George J; Poustchi H; Malekzadeh R
    J Viral Hepat; 2016 Oct; 23(10):805-11. PubMed ID: 27126365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of Booster Response to Hepatitis B Vaccine at 15 years of age: A Cross-Sectional School-Based Study.
    Chen YS; Chu CH; Wang JH; Lin JS; Chang YC
    Pediatr Neonatol; 2016 Aug; 57(4):302-9. PubMed ID: 26750404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence of Low Seroimmunity to Hepatitis B Virus in Children With Inflammatory Bowel Disease.
    Watts A; Bennett WE; Molleston JP; Gupta SK; Croffie JM; Waseem S; McFerron BA; Steiner SJ; Kumar S; Vanderpool CP; Hon EC; Bozic MA; Subbarao GC; Pfefferkorn MD
    J Pediatr Gastroenterol Nutr; 2017 Nov; 65(5):551-554. PubMed ID: 28333769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity of Augmented Compared With Standard Dose Hepatitis B Vaccine in Pediatric Patients on Dialysis: a Midwest Pediatric Nephrology Consortium Study.
    Misurac JM; VanDeVoorde RG; Kallash M; Iorember FM; Luckritz KE; Rheault MN; Jetton JG; Turman MA; Kapur G; Twombley KE; Hashmat S; Weaver DJ; Leiser JD; Nailescu C
    Clin J Am Soc Nephrol; 2017 May; 12(5):772-778. PubMed ID: 28270432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody Response to Hepatitis B Virus Vaccine is Impaired in Patients With Inflammatory Bowel Disease on Infliximab Therapy.
    Pratt PK; David N; Weber HC; Little FF; Kourkoumpetis T; Patts GJ; Weinberg J; Farraye FA
    Inflamm Bowel Dis; 2018 Jan; 24(2):380-386. PubMed ID: 29361083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased immune response to hepatitis B eight years after routine vaccination in Israel.
    Gold Y; Somech R; Mandel D; Peled Y; Reif S
    Acta Paediatr; 2003 Oct; 92(10):1158-62. PubMed ID: 14632331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long term immune response of universal hepatitis B vaccination in infancy: a community-based study in Taiwan.
    Shih HH; Chang MH; Hsu HY; Lee PI; Ni YH; Chen DS
    Pediatr Infect Dis J; 1999 May; 18(5):427-32. PubMed ID: 10353515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficient haemodialysis improves the response to hepatitis B virus vaccination.
    Kovacic V; Sain M; Vukman V
    Intervirology; 2002; 45(3):172-6. PubMed ID: 12403922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B virus vaccination and revaccination response in children diagnosed with coeliac disease : a multicentre prospective study.
    Rousseff T; Claeys T; Vande Vijver E; Moes N; Vande Velde S; Schelstraete P; De Bruyne R; Van Winckel M; Van Biervliet S
    Acta Gastroenterol Belg; 2019; 82(1):27-30. PubMed ID: 30888750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term follow-up of Hepatitis B Surface antibody levels in subjects receiving universal Hepatitis B vaccination in infancy in an area of hyperendemicity: correlation between radioimmunoassay and enzyme immunoassay.
    Wang CW; Wang LC; Chang MH; Ni YH; Chen HL; Hsu HY; Chen DS
    Clin Diagn Lab Immunol; 2005 Dec; 12(12):1442-7. PubMed ID: 16339069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Is it necessary to revaccinate against hepatitis B virus when the titer of anti-HBs drops below 10 IU/L?].
    Polák P; Husa P; Smejkal P; Kamelander J; Chlupová G; Penka M
    Klin Mikrobiol Infekc Lek; 2016 Sep; 22(3):125-130. PubMed ID: 27907975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The long-term immunogenicity of recombinant hepatitis B virus (HBV) vaccine: contribution of universal HBV vaccination in Italy.
    Coppola N; Corvino AR; De Pascalis S; Signoriello G; Di Fiore E; Nienhaus A; Sagnelli E; Lamberti M
    BMC Infect Dis; 2015 Mar; 15():149. PubMed ID: 25884719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Markedly decreased antibody titers against hepatitis B in previously immunised children presenting with juvenile idiopathic arthritis.
    Maritsi D; Vartzelis G; Soldatou A; Garoufi A; Spyridis N
    Clin Exp Rheumatol; 2013; 31(6):969-73. PubMed ID: 23806191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of hepatitis B surface antibody decay rates after vaccination between hemodialysis and peritoneal dialysis patients.
    Lin SY; Liu JH; Lin CC; Wang SM; Tsai CA; Chou CY; Kuo HL; Wang IK; Liu YL; Lin HH; Huang CC
    Vaccine; 2011 May; 29(21):3738-41. PubMed ID: 21458609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Duration of protection after infant hepatitis B vaccination series.
    Middleman AB; Baker CJ; Kozinetz CA; Kamili S; Nguyen C; Hu DJ; Spradling PR
    Pediatrics; 2014 Jun; 133(6):e1500-7. PubMed ID: 24843060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term response rates of successful hepatitis B vaccination in HIV-infected patients.
    Lopes VB; Hassing RJ; de Vries-Sluijs TE; El Barzouhi A; Hansen BE; Schutten M; de Man RA; van der Ende ME
    Vaccine; 2013 Feb; 31(7):1040-4. PubMed ID: 23273969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective interventional study of tenofovir in pregnancy to prevent vertical transmission of hepatitis B in highly viremic women.
    Sellier PO; Maylin S; Berçot B; Chopin D; Lopes A; Simoneau G; Evans J; Delcey V; Bénifla JL; Simon F; Bergmann JF
    Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):259-263. PubMed ID: 27879486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.